dibekacin and Cystic-Fibrosis

dibekacin has been researched along with Cystic-Fibrosis* in 2 studies

Other Studies

2 other study(ies) available for dibekacin and Cystic-Fibrosis

Article	Year
[Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population]. Annales de pediatrie, 1987, Volume: 34, Issue:9 Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Dibekacin; Female; Humans; Kanamycin; Male; Ticarcillin	1987
Pharmacokinetics of dibekacin in children with cystic fibrosis. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:2 Dosages and pharmacokinetics of dibekacin were studied in a group of 15 children with cystic fibrosis (CF) and a control group of 9 children. The mean dosage regimens of dibekacin were respectively equal to 2.19 mg/kg and 2.16 mg/kg in the CF and non-CF patients. The mean peak serum values for the CF and non-CF groups were respectively equal to 5.3 micrograms/ml. Comparison of pharmacokinetic parameters (i.e. half-life, distribution volume, total body clearance and area under the curve) showed no significant difference between the two groups (p greater than 0.05). Topics: Aspartate Aminotransferases; Child; Creatinine; Cystic Fibrosis; Dibekacin; Humans; Kanamycin; Kinetics; Time Factors	1985

Article

Year

[Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population].

Annales de pediatrie, 1987, Volume: 34, Issue:9

Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Dibekacin; Female; Humans; Kanamycin; Male; Ticarcillin

1987

Pharmacokinetics of dibekacin in children with cystic fibrosis.

International journal of clinical pharmacology research, 1985, Volume: 5, Issue:2

Dosages and pharmacokinetics of dibekacin were studied in a group of 15 children with cystic fibrosis (CF) and a control group of 9 children. The mean dosage regimens of dibekacin were respectively equal to 2.19 mg/kg and 2.16 mg/kg in the CF and non-CF patients. The mean peak serum values for the CF and non-CF groups were respectively equal to 5.3 micrograms/ml. Comparison of pharmacokinetic parameters (i.e. half-life, distribution volume, total body clearance and area under the curve) showed no significant difference between the two groups (p greater than 0.05).

Topics: Aspartate Aminotransferases; Child; Creatinine; Cystic Fibrosis; Dibekacin; Humans; Kanamycin; Kinetics; Time Factors

1985